US HB2674 | 2011-2012 | 112th Congress
Status
Sponsorship: Bipartisan Bill
Status: Introduced on July 27 2011 - 25% progression, died in committee
Action: 2011-08-01 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 27 2011 - 25% progression, died in committee
Action: 2011-08-01 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
340B Program Improvement Act - Amends the Public Health Service Act to make revisions to the 340B drug discount program (a program limiting the cost of covered outpatient drugs to certain federal grantees). Includes drugs used in connection with an inpatient or outpatient service by enrolled hospitals as covered drugs under the program (currently, only outpatient drugs are covered under the program). Requires hospitals enrolled in the 340B program to provide to each state a credit on the estimated annual purchases by such hospitals of covered drugs provided to Medicaid recipients for inpatient use. Sets forth a formula for calculating the credit. Allows a hospital to avoid paying such credits under certain circumstances. Eliminates the requirement that hospitals enrolled in the 340B program report the National Drug Code numbers for drugs administered by a physician if the state is precluded from seeking a rebate on such drugs because they were purchased at a discount under the 340B program. Removes the exclusion that prohibited covered entities added to the 340B program under the Patient Protection and Affordable Care Act from purchasing drugs for a rare disease or condition as covered outpatient drugs. Treats a facility or organization that is eligible for the 340B program as satisfying any geographic location requirements in relation to a hospital or a critical access hospital for purposes of determining provider-based status under Medicare.
Title
340B Program Improvement Act
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2011-08-01 | House | Referred to the Subcommittee on Health. |
| 2011-08-01 | House | Referred to the Subcommittee on Health. |
| 2011-07-27 | House | Referred to House Ways and Means |
| 2011-07-27 | House | Referred to House Energy and Commerce |
| 2011-07-27 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
Same As/Similar To
HB5194 (Related) 2012-05-02 - Referred to the Subcommittee on Health.
HB5624 (Related) 2012-05-15 - Referred to the Subcommittee on Health.
HB5624 (Related) 2012-05-15 - Referred to the Subcommittee on Health.
Subjects
Business records
Health
Health care costs and insurance
Health facilities and institutions
Medicaid
Medicare
Prescription drugs
Health
Health care costs and insurance
Health facilities and institutions
Medicaid
Medicare
Prescription drugs
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/112th-congress/house-bill/2674/all-info |
| Text | https://www.congress.gov/112/bills/hr2674/BILLS-112hr2674ih.pdf |
